welcome
Reuters

Reuters

Health

Health

Roche pairs with Zealand Pharma on obesity drug candidate

Reuters
Summary
Nutrition label

81% Informative

Danish drug maker Zealand Pharma to co-develop petrelintide as an obesity therapy drug.

Zealand Pharma will receive upfront cash payments of $1.65 billion , with the possibility of milestone payments of up to $5.3 billion based on a phase 3 trial and sales development.

VR Score

90

Informative language

95

Neutral language

82

Article tone

formal

Language

English

Language complexity

61

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.